Optibrium appoints Clare Devlin as FD as it plots growth
Drug discovery software company Optibrium has appointed Clare Devlin as financial director as it eyes expansion.
Clare, who held FD roles at Scintacor, Addviso and Genestack, arrives following the company’s move last year to Cambridge Innovation Park in Waterbeach, the recruitment of three more software engineers and the release of StarDrop 6.5, the latest version of its lead product.
CEO Dr Matthew Segall said: “The appointment of Clare and the strengthening of our software development team form part of ambitious growth plans and mission to accelerate our R&D pipeline. This will enable us to extend our research into new technologies that improve the efficiency and productivity of the drug discovery process.
“As the company matures, we’re investing in key senior and technical roles to maintain corporate development and help bring new product features to our clients quicker. I am delighted to welcome the new members of our multidisciplinary team.”
Clare said: “Optibrium’s rapid revenue growth in 2018 has set a great foundation for further growth this year. I look forward to assisting the company with their continued business development and corporate expansion.”